- [PRESSWIRE] Vancouver, British Columbia – May 31, 2023 — NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce that it has established a new British Columbia subsidiary, 1416753 B.C. Ltd. (“SubCo”) to focus on its high-grade Ptarmigan silver-copper-lead-zinc project in southeastern BC. SubCo has also entered into an option agreement dated May 26, 2023 (the “Option Agreement”) to acquire a portfolio of advanced exploration assets including two copper-gold-silver projects and three lithium projects in British Columbia (collectively, the “Option Projects”) from Eagle Plains Resources Ltd. (“EPL” or the “Optionor”, TSXV:EPL). The Option Agreement and Option Projects are described in more detail below.
- [PRESSWIRE] Zurich / Pfäffikon SZ, Switzerland; Lincoln, MA, U.S.A. – 25.05.2023 — WebAccountPlus (Holding) AG, the Swiss Fintech StartUp of the next decade, announces worldwide exclusive partnership with ESM Software, LLC for Micro and Small Business owners / SMEs up to 50 employees. (Larger companies can also be integrated on the platform on a case-by-case basis). ESM is one of the world’s top leading Software Provider when it comes to Strategy and Performance Management or Cyber Risks.
- [PRESSWIRE] Estonia – 09.05.23 — Buggyra ZM Racing claimed its first 24H GT Series victory of the season as Aliyyah Koloc, Adam Lacko, and David Vršecky came out on top in dominant fashion in the 12 Hours of Spa-Francorchamps, winning with a three-lap margin. They are now leading the drivers’ and teams’ championship in the GT4 class by 12 points.
- [PRESSWIRE] Vienna, Austria – 02.05.2003 — CEBINA GmbH, Central European Biotech Incubator and Accelerator, today announces the publication of the positive results of a Phase 2 clinical study that tested azelastine nasal spray as a new approach for reducing viral load in the nose of SARS-CoV-2 positive patients in the peer-reviewed journal Scientific Reports (1).
- [PRESSWIRE] TORONTO, Ontario and CAMBRIDGE, Massachusetts – April 25, 2023 – ProMIS Neurosciences Inc. (TSX: PMN) (Nasdaq: PMN), a biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), today presented preclinical data supporting the development of a computationally-derived amyloid-beta (Aβ) vaccine for AD at the American Academy of Neurology (AAN) 2023 Annual Meeting.
- PMN310 demonstrated greater selectivity for target toxic oligomers over monomers compared to other amyloid-beta-directed antibodies Greater selectivity of PMN310 for toxic oligomers indicates a potentially differentiated profile and supports further development
- [PRESSWIRE] PORTUGAL – 24.03.23 — Tonic App launches ChatGPT assistant to support physicians with medical, admin and personal tasks…
- [PRESSWIRE] Israel – 23.02.23 — Israeli artist Orit Fuchs is preparing for two upcoming solo exhibitions in Cleveland and Atlanta, scheduled to open in May 2023. The artist, whose work has gained her international recognition, is known for her unique style and captivating paintings. In a recent interview, Fuchs expressed her excitement about the upcoming exhibitions, sharing her belief that every work of art should be an expression of the artist’s true self.
- [PRESSWIRE] Israel – 22.02.23 — Orit Fuchs is an international artist based in Tel Aviv, Israel. who is making waves in the art world. Her unique style and captivating paintings have gained her international recognition and a dedicated following of art lovers.
- [PRESSWIRE] London, UK – 02.02.23 — Returners schemes, transferable skills, boosting staff confidence and more. Join WISE and partners as we inspire employers to recruit, support and progress women in STEM careers, while helping women themselves to recognise their potential and celebrate their achievements.
